| 000 | 01753 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250514210637.0 | ||
| 264 | 0 | _c20050103 | |
| 008 | 200501s 0 0 eng d | ||
| 022 | _a0022-2623 | ||
| 024 | 7 |
_a10.1021/jm040863t _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChambers, Mark S | |
| 245 | 0 | 0 |
_aAn orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cNov 2004 |
||
| 300 |
_a5829-32 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBinding Sites |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 |
_aCognition _xdrug effects |
| 650 | 0 | 4 | _aDogs |
| 650 | 0 | 4 | _aGABA-A Receptor Agonists |
| 650 | 0 | 4 |
_aIsoxazoles _xadverse effects |
| 650 | 0 | 4 |
_aMaze Learning _xdrug effects |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNootropic Agents _xadverse effects |
| 650 | 0 | 4 | _aPatch-Clamp Techniques |
| 650 | 0 | 4 | _aProtein Subunits |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, GABA-A _xmetabolism |
| 650 | 0 | 4 |
_aTriazines _xadverse effects |
| 700 | 1 | _aAtack, John R | |
| 700 | 1 | _aCarling, Robert W | |
| 700 | 1 | _aCollinson, Neil | |
| 700 | 1 | _aCook, Susan M | |
| 700 | 1 | _aDawson, Gerard R | |
| 700 | 1 | _aFerris, Pushpindar | |
| 700 | 1 | _aHobbs, Sarah C | |
| 700 | 1 | _aO'connor, Desmond | |
| 700 | 1 | _aMarshall, George | |
| 700 | 1 | _aRycroft, W | |
| 700 | 1 | _aMacleod, Angus M | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 47 _gno. 24 _gp. 5829-32 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/jm040863t _zAvailable from publisher's website |
| 999 |
_c15224633 _d15224633 |
||